Agenda – Medical Imaging in Clinical Research

  • Day 1
  • Day 2

Day 1

 Monday, February 12, 2018

9:30AM – 10:00AM

Chairperson’s Opening Remarks — Advanced Methods for Read Designs and Inter-Reader Variability
Colin Miller, Editor, MEDICAL IMAGING IN CLINICAL TRIALS

10:00AM – 11:00AM

Strategically Plan and Manage Imaging in Your Clinical Trial to Ensure Standardization Across Vendors
Neeta Fahey, Clinical Imaging Operations, Senior Clinical Protocol Manager, BRISTOL-MYERS SQUIBB

11:00AM – 11:30AM

Networking Break

11:30AM – 12:30PM

Implement PET Imaging As a Potential Go/ No-Go Decision in Early-Phase Clinical Trials
Jianqing Chen, PET and Molecular Imaging, PFIZER

12:30PM – 1:45PM

Luncheon

1:45PM – 2:45PM

Incorporate Experimental Imaging Agents in Drug Clinical Trials
Youngho Seo, Ph.D., Professor, Department of Radiology and Biomedical Imaging, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Gary Ulaner, M.D., Ph.D., Associate Attending Radiologist, MEMORIAL SLOAN KETTERING CANCER CENTER

2:45PM – 3:45PM

Adopt Electronic Transfer of Imaging Data Across the Industry
Shawn Keen, Associate Director, Imaging Partner Relationship Lead, BRISTOL-MYERS SQUIBB

3:45PM – 4:45PM

Operationalize Imaging Management in Clinical Research Trials
Debbie N. Coté, RN, Director, Clinical Operations, NEKTAR THERAPEUTICS


Day 2

 Tuesday, February 13, 2018

8:00AM – 9:00AM

Continental Breakfast

10:30AM – 11:30AM

Reader Challenges in Central Independent Reviews
Ira Smalberg, M.D., Diagnostic Radiology, TOWER IMAGING MEDICAL GROUP

11:30AM – 12:00PM

Networking Break

12:00PM – 1:00PM

Treatment of Neurological Disorders Using Molecular Imaging As a Guide
Dr. Johan Luthman, VP Neuroscience Clinical Development, EISAI

1:00PM – 2:15PM

Luncheon

2:15PM – 3:15PM

Utilize Imaging Modalities for Randomization and Endpoint Adjudication
Priya Guyadeen, Clinical Project Manager, Peripheral, PENUMBRA, INC.

4:15PM – 4:30PM

Chairperson’s Closing Remarks
Colin Miller, Editor, MEDICAL IMAGING IN CLINICAL TRIALS